Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Dealsbenzinga_article·12 hours agoJNJ-3.66%
J&J’s Rybrevant Faspro wins FDA priority review for advanced head and neck cancer treatmentPUBT·15 hours agoJNJ-3.66%
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation | JNJ Stock NewsStockTitan·1 day ago, 08:42 AMJNJ-3.66%
The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For VitiligoSimplywall·1 day ago, 06:30 AMABBV-2.24%
Behzad Aghazadeh Holds Board Seat at Scribe Therapeutics with 16.37% StakeTradingView·2 hours agoSCTX+11.11%LLY-4.55%
Johnson & Johnson Stock (JNJ) Moved Down by 3.49% on Jul 30: Key Drivers UnveiledTradingKey·11 hours agoJNJ-3.66%
UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarket Beat·21 hours agoUNH+0.21%UNHG+0.40%
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata | ABBV Stock NewsStockTitan·2 days ago, 06:00 PMABBV-2.24%
14:16 ETMilberg Helps Deliver Historic Uncapped Settlement for 70,000 Women in J&J Talcum Powder Litigationprnewswire·2 days ago, 01:17 PMJNJ-3.66%
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset | JNJ Stock NewsStockTitan·1 day ago, 08:28 AMJNJ-3.66%
AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full AnalysisTradingKey·2 days ago, 10:18 AMABBV-2.24%
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo | ABBV Stock NewsStockTitan·2 days ago, 06:00 PMABBV-2.24%
Talon Private Wealth LLC Makes New $1.36 Million Investment in Johnson & Johnson $JNJMarket Beat·1 day ago, 05:09 AMJNJ-3.66%
J&J's Proposed $5.5 Billion Talc Settlement May "Lift Remaining Overhang" On Shares, Says GuggenheimZeroHedge·2 days ago, 08:42 AMJNJ-3.66%
